Public reporting of patient outcomes is an important tool to improve quality of care, but some observers worry that such efforts will lead clinicians to avoid high-risk patients.
To determine whether public reporting for percutaneous coronary intervention (PCI) is associated with lower rates of PCI for patients with acute myocardial infarction (MI) or with higher mortality rates in this population.
Design, Setting, and Patients
Retrospective observational study conducted using data from fee-for-service Medicare patients (49,660 from reporting states and 48,142 from nonreporting states) admitted with acute Ml to US acute care hospitals between 2002 and 2010. Logistic regression was used to compare PCI and mortality rates between reporting states (New York, Massachusetts, and Pennsylvania) and regional nonreporting states (Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware). Changes in PCI rates over time in Massachusetts compared with nonreporting states were also examined.
Main Outcome Measures
Risk-adjusted PCI and mortality rates.
In 2010, patients with acute MI were less likely to receive PCI in public reporting states than in nonreporting states (unadjusted rates, 37.7% vs. 42.7%, respectively; risk-adjusted odds ratio [OR], 0.82, 95% CI, 0.71–0.93, P=.003). Differences were greatest among the 6708 patients with ST-segment elevation Ml (61.8% vs 68.0%; OR, 0.73 [95% CI, 0.59–0.89]; P=.002) and the 2194 patients with cardiogenic shock or cardiac arrest (41.5% vs 46.7%, OR 0.79 [0.64, 0.98], P=.030). In Massachusetts, odds of PCI for acute Ml were comparable with odds in nonreporting states prior to public reporting (40.6% versus 41.8%, OR 1.00 [0.71, 1.41]). However, after implementation of public reporting, odds of undergoing PCI in Massachusetts decreased compared with nonreporting states (41.1% versus 45.6%, OR 0.81 [0.47, 1.38], p=.030 for difference in differences). Differences were most pronounced for the 6081 patients with cardiogenic shock or cardiac arrest (pre-reporting, 44.2% versus 36.6%, OR 1.40 [0.85, 2.37] post-reporting, 43.9% versus 44.8%, OR 0.92 [0.38, 2.22], p=.028 for difference in differences). There were no differences in overall mortality among acute MI patients in reporting versus non-reporting states.
Among Medicare beneficiaries with acute Ml, the use of PCI was lower for patients treated in 3 states with public reporting of PCI outcomes compared with patients treated in 7 regional control states without public reporting. However, there was no difference in overall acute Ml mortality between states with and without public reporting.